Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D00TRY
|
|||
| Former ID |
DNC003255
|
|||
| Drug Name |
Tert-Butyl(1s)-1-Cyclohexyl-2-Oxoethylcarbamate
|
|||
| Synonyms |
TERT-BUTYL(1S)-1-CYCLOHEXYL-2-OXOETHYLCARBAMATE; CHEMBL92567; tert-butyl N-[(1S)-1-cyclohexyl-2-oxoethyl]carbamate; 1q6k; AC1L9LIG; SCHEMBL8259018; BDBM50137816; DB04523; (S)-tert-butyl (1-cyclohexyl-2-oxoethyl)carbamate; tert-butyl [(1S)-1-cyclohexyl-2-oxoethyl]carbamate; ((S)-1-Cyclohexyl-2-oxo-ethyl)-carbamic acid tert-butyl ester
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C13H23NO3
|
|||
| Canonical SMILES |
CC(C)(C)OC(=O)NC(C=O)C1CCCCC1
|
|||
| InChI |
1S/C13H23NO3/c1-13(2,3)17-12(16)14-11(9-15)10-7-5-4-6-8-10/h9-11H,4-8H2,1-3H3,(H,14,16)/t11-/m1/s1
|
|||
| InChIKey |
BDSGOSWEKUGHOV-LLVKDONJSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Cathepsin K (CTSK) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Lysosome | |||
| Osteoclast differentiation | ||||
| Toll-like receptor signaling pathway | ||||
| Rheumatoid arthritis | ||||
| NetPath Pathway | TGF_beta_Receptor Signaling Pathway | |||
| RANKL Signaling Pathway | ||||
| IL2 Signaling Pathway | ||||
| Reactome | Collagen degradation | |||
| Degradation of the extracellular matrix | ||||
| Activation of Matrix Metalloproteinases | ||||
| Trafficking and processing of endosomal TLR | ||||
| MHC class II antigen presentation | ||||
| WikiPathways | RANKL/RANK Signaling Pathway | |||
| Osteoclast Signaling | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.